Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10376
Northern Trust High Yield Value-Scored Bond ETF
HYGV
$1.03B
| $206K | ﹤0.01% |
5,054
-7,624
| -60% | -$314K |
2024 Q2
2 quarters
|
|
|
NNOV
10377
Innovator Growth-100 Power Buffer ETF - November
NNOV
$80.2M
| $205K | ﹤0.01% |
+7,955
| New | +$205K |
2024 Q4
0 quarters
|
|
10378
Soluna Holdings
SLNH
$227M
| $205K | ﹤0.01% |
97,585
+83,409
| +588% | +$276K |
2024 Q3
1 quarter
|
|
10379
PUT
AZZ Inc
AZZ
$4.09B
| $205K | ﹤0.01% |
2,500
-3,600
| -59% | -$305K |
2022 Q4
8 quarters
|
|
|
OZEM
10380
PUT
Roundhill GLP-1 & Weight Loss ETF
OZEM
$54.9M
| $205K | ﹤0.01% |
8,400
+8,100
| +2,700% | +$218K |
2024 Q2
2 quarters
|
|
10381
Avantis US Large Cap Equity ETF
AVLC
$1.53B
| $204K | ﹤0.01% |
+3,027
| New | +$206K |
2024 Q4
0 quarters
|
|
10382
Vaalco Energy
EGY
$640M
| $204K | ﹤0.01% |
46,755
-52,398
| -53% | -$278K |
2024 Q3
1 quarter
|
|
10383
CALL
UWM Holdings
UWMC
$376M
| $204K | ﹤0.01% |
34,800
+18,400
| +112% | +$120K |
2020 Q4
16 quarters
|
|
|
WIMI
10384
PUT
WiMi Hologram Cloud
WIMI
$11.8M
| $204K | ﹤0.01% |
11,030
+9,110
| +474% | +$87.1K |
2022 Q4
8 quarters
|
|
10385
Anixa Biosciences
ANIX
$103M
| $204K | ﹤0.01% |
87,919
+82,234
| +1,447% | +$255K |
2024 Q3
1 quarter
|
|
10386
CALL
Bally's
BALY
$704M
| $204K | ﹤0.01% |
11,400
-107,700
| -90% | -$1.9M |
2022 Q3
9 quarters
|
|
10387
PUT
Trevi Therapeutics
TRVI
$1.85B
| $204K | ﹤0.01% |
49,500
+45,000
| +1,000% | +$144K |
2024 Q3
1 quarter
|
|
|
GRW
10388
TCW ETF Trust TCW Durable Growth ETF
GRW
$63M
| $204K | ﹤0.01% |
6,205
+491
| +9% | +$18.3K |
2024 Q3
1 quarter
|
|
10389
CALL
Lightbridge
LTBR
$215M
| $204K | ﹤0.01% |
43,100
+36,000
| +507% | +$215K |
2022 Q4
8 quarters
|
|
|
GRVY
10390
GRAVITY
GRVY
$467M
| $204K | ﹤0.01% |
+3,228
| New | +$207K |
2024 Q4
0 quarters
|
|
|
SLP
10391
PUT
DELISTED
Simulations Plus
SLP
| $204K | ﹤0.01% |
7,300
+5,900
| +421% | +$180K |
2022 Q3
9 quarters
|
|
|
FOLD
10392
CALL
DELISTED
Amicus Therapeutics
FOLD
| $203K | ﹤0.01% |
21,600
-27,000
| -56% | -$281K |
2014 Q3
41 quarters
|
|
10393
PUT
UMB Financial
UMBF
$9.83B
| $203K | ﹤0.01% |
1,800
-600
| -25% | -$69.4K |
2022 Q4
8 quarters
|
|
10394
PUT
Silgan Holdings
SLGN
$3.75B
| $203K | ﹤0.01% |
3,900
+2,700
| +225% | +$144K |
2022 Q4
8 quarters
|
|
|
CMRX
10395
PUT
DELISTED
Chimerix, Inc.
CMRX
| $203K | ﹤0.01% |
58,300
+2,500
| +4% | +$3.53K |
2022 Q4
8 quarters
|
|
10396
PUT
Laser Photonics
LASE
$45.2M
| $203K | ﹤0.01% |
35,100
+29,000
| +475% | +$180K |
2024 Q3
1 quarter
|
|
|
BANX
10397
PUT
ArrowMark Financial
BANX
$191M
| $203K | ﹤0.01% |
9,700
+2,900
| +43% | +$59.8K |
2024 Q3
1 quarter
|
|
10398
CALL
ROBO Global Robotics & Automation Index ETF
ROBO
$2.04B
| $203K | ﹤0.01% |
3,600
+1,000
| +38% | +$56.9K |
2022 Q3
9 quarters
|
|
10399
PUT
State Street SPDR Portfolio TIPS ETF
SPIP
$1.01B
| $202K | ﹤0.01% |
8,000
| – | – |
2023 Q1
7 quarters
|
|
|
ZENA
10400
ZenaTech Inc
ZENA
$106M
| $202K | ﹤0.01% |
+26,320
| New | +$115K |
2024 Q4
0 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.